FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 305:533-538 September 3, 1981 Number 10 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We have recently described an in vitro clonal assay system for human megakaryocyte-progenitor cells or megakaryocytic colony-forming units (CFU-M). Serum specimens from patients with quantitative platelet disorders were screened for the capacity to alter in vitro megakaryocyte-colony formation. Serum from 11 patients with hypomegakaryocytic thrombocytopenia significantly enhanced the formation of CFU-M-derived colonies (200 to 1840 per cent). Neither serum from eight patients with thrombocytopenia and normal or increased numbers of marrow megakaryocytes nor serum from 11 patients with thrombocytosis altered colony formation. This stimulatory activity has been termed megakaryocytic-colony-stimulating activity (Meg-CSA). The number of megakaryocytic colonies formed was directly proportional to the quantity of stimulatory serum added. Meg-CSA levels appeared to be inversely related to marrow megakaryocyte numbers. The variations in Meg-CSA levels that were detected in different disease states suggest that alterations in the production of this stem-cell regulator have physiologic importance.

This article has been cited by other articles:

• Tauro, S., Prasad, K., Bussel, J. B., Kuter, D. J., Nichol, J. L. (2007). AMG 531 for Chronic ITP. NEJM 356: 307-308 [Full Text]  
• McMillan, R., Wang, L., Tomer, A., Nichol, J., Pistillo, J. (2004). Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 103: 1364-1369 [Abstract] [Full Text]  
• Chang, M., Nakagawa, P. A., Williams, S. A., Schwartz, M. R., Imfeld, K. L., Buzby, J. S., Nugent, D. J. (2003). Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood 102: 887-895 [Abstract] [Full Text]  
• Frey, B. M., Rafii, S., Teterson, M., Eaton, D., Crystal, R. G., Moore, M. A.S. (1998). Adenovector-Mediated Expression of Human Thrombopoietin cDNA in Immune-Compromised Mice: Insights into the Pathophysiology of Osteomyelofibrosis. J. Immunol. 160: 691-699 [Abstract] [Full Text]  
• Murone, M., Carpenter, D. A., de Sauvage, F. J. (1998). Hematopoietic Deficiencies in c-mpl and TPO Knockout Mice. Stem Cells 16: 1-6 [Abstract] [Full Text]  
• Shivdasani, R. A., Fielder, P., Keller, G.-A., Orkin, S. H., de Sauvage, F. J. (1997). Regulation of the Serum Concentration of Thrombopoietin in Thrombocytopenic NF-E2 Knockout Mice. Blood 90: 1821-1827 [Abstract] [Full Text]  
• Gurney, A., Carver-Moore, K, de Sauvage, F., Moore, M. (1994). Thrombocytopenia in c-mpl-deficient mice. Science 265: 1445-1447 [Abstract]